Altium Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,667
| Closed | -$3.31M | – | 136 |
|
|
2022
Q3 | $3.31M | Hold |
14,667
| – | – | 1.21% | 33 |
|
|
2022
Q2 | $2.77M | Hold |
14,667
| – | – | 1.11% | 31 |
|
|
2022
Q1 | $3.65M | Buy |
14,667
+5,967
| +69% | +$1.49M | 1.22% | 34 |
|
|
2021
Q4 | $1.36M | Buy |
8,700
+2,117
| +32% | +$330K | 0.37% | 81 |
|
|
2021
Q3 | $1.32M | Hold |
6,583
| – | – | 0.35% | 85 |
|
|
2021
Q2 | $1.68M | Hold |
6,583
| – | – | 0.39% | 90 |
|
|
2021
Q1 | $1.75M | Hold |
6,583
| – | – | 0.49% | 87 |
|
|
2020
Q4 | $2.43M | Buy |
+6,583
| New | +$2.43M | 0.91% | 47 |
|